Abstract
The use of the nasal route for drug delivery has attracted much interest in recent years in the pharmaceutical field. Local and principally systemic drug delivery can be achieved by this route of administration. But the nasal route of delivery is not applicable to all drugs. Polar drugs and some macromolecules are not absorbed in sufficient concentration due to poor membrane permeability, rapid clearance and enzymatic degradation into the nasal cavity. Thus, alternative means that help overcome these nasal barriers are currently in development. Absorption enhancers such as phospholipids and surfactants are constantly used, but care must be taken in relation to their concentration. Drug delivery systems including liposomes, cyclodextrins, micro- and nanoparticles are being investigated to increase the bioavailability of drugs delivered intranasally. This review article discusses recent progress and specific development issues relating to colloidal drug delivery systems in nasal drug delivery.
Keywords: Nasal delivery, nasal bioavailability, colloidal drug delivery systems
Current Drug Delivery
Title: Liposomes and Micro/Nanoparticles as Colloidal Carriers for Nasal Drug Delivery
Volume: 3 Issue: 3
Author(s): Rubiana Mara Mainardes, Maria Cristina Cocenza Urban, Priscila Oliveira Cinto, Marco Vinicius Chaud, Raul Cesar Evangelista and Maria Palmira Daflon Gremiao
Affiliation:
Keywords: Nasal delivery, nasal bioavailability, colloidal drug delivery systems
Abstract: The use of the nasal route for drug delivery has attracted much interest in recent years in the pharmaceutical field. Local and principally systemic drug delivery can be achieved by this route of administration. But the nasal route of delivery is not applicable to all drugs. Polar drugs and some macromolecules are not absorbed in sufficient concentration due to poor membrane permeability, rapid clearance and enzymatic degradation into the nasal cavity. Thus, alternative means that help overcome these nasal barriers are currently in development. Absorption enhancers such as phospholipids and surfactants are constantly used, but care must be taken in relation to their concentration. Drug delivery systems including liposomes, cyclodextrins, micro- and nanoparticles are being investigated to increase the bioavailability of drugs delivered intranasally. This review article discusses recent progress and specific development issues relating to colloidal drug delivery systems in nasal drug delivery.
Export Options
About this article
Cite this article as:
Mara Mainardes Rubiana, Cristina Cocenza Urban Maria, Oliveira Cinto Priscila, Vinicius Chaud Marco, Cesar Evangelista Raul and Palmira Daflon Gremiao Maria, Liposomes and Micro/Nanoparticles as Colloidal Carriers for Nasal Drug Delivery, Current Drug Delivery 2006; 3 (3) . https://dx.doi.org/10.2174/156720106777731019
DOI https://dx.doi.org/10.2174/156720106777731019 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Blood-Brain-Barrier Models for the Investigation of Transporter- and Receptor-Mediated Amyloid-β Clearance in Alzheimers Disease
Current Alzheimer Research Delivery of Neurotherapeutics Across the Blood Brain Barrier in Stroke
Current Pharmaceutical Design Artificial Intelligence for Epigenetics: Towards Personalized Medicine
Current Medicinal Chemistry Tuberculostatic Drugs Targeting Infections of the Central Nervous System
Anti-Infective Agents Brain Delivery Systems via Mechanism Independent of Receptor-Mediated Endocytosis and Adsorptive-Mediated Endocytosis
Current Pharmaceutical Biotechnology Tauopathies – Focus on Changes at the Neurovascular Unit
Current Alzheimer Research Aquaporins and Glia
Current Neuropharmacology Pharmaceutical Targeting of the Brain
Current Pharmaceutical Design Antisense Oligonucleotides in the Treatment of Cerebral Gliomas. Review of Concerning Patents
Recent Patents on CNS Drug Discovery (Discontinued) Novel Agents in CNS Myeloma Treatment
Central Nervous System Agents in Medicinal Chemistry Inflammatory Events Following Subarachnoid Hemorrhage (SAH)
Current Neuropharmacology Post Dural Puncture Headache and Hypertension
Current Hypertension Reviews The Role of Adenosine in Rheumatoid Arthritis
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Ion Transporters in Brain Tumors
Current Medicinal Chemistry Imaging and Clinical Features of Neurocutaneous Melanosis in the Pediatric Population
Current Medical Imaging HTLV-1 Associated Neurological Disorders
Current Topics in Medicinal Chemistry Glioma Dynamics and Computational Models: A Review of Segmentation, Registration, and In Silico Growth Algorithms and their Clinical Applications
Current Medical Imaging Relevant Modulation by Ferrous Ions of N-Methyl-D-Aspartate Receptors in Ischemic Brain Injuries
Current Neurovascular Research The Current WHO Classification of Tumours of the Central Nervous System: Histopathology and Additional Diagnostic Methods
Current Medical Imaging Protection Mechanisms Against Aβ42 Aggregation
Current Alzheimer Research